NEW YORK – Researchers from the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) have generated multi-omic profiles for clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, defining subtypes that might be useful to stratify patients for treatment.